Study Investigates Effectiveness of FDA-Approved Fast-Tracked Drugs, Particularly in Cancer Treatment
Research Reveals Many Fast-Tracked Cancer Drugs Lack Clear Benefits Within Five Years, Prompting Concerns
According to The Columbian, a recent study looked at how well fast-tracked drugs approved by the FDA actually work, especially for cancer treatment. They found that many cancer drugs approved this way didn’t show clear benefits within five years. Even though these drugs are meant to give patients early access to promising treatments, the study raised concerns about not knowing for sure if they work.
READ ALSO: Eyedrop Safety Amid Recalls – What You Need To Know
5 Years Post-Approval Unproven Cancer Drugs – Study Reveals Alarming Truth! (PHOTO: WRAL.com)
Dr. Ezekiel Emanuel‘s Research Reveals Disparity Between Effectiveness and Approval Rate of Cancer Drugs
Dr. Ezekiel Emanuel‘s study on cancer drugs from 2013-2017 found only 43% showed benefits in follow-up trials, yet 63% got full approval. This underscores the need for better testing and communication about drug effectiveness. Recent changes aim to give the FDA more power for patient safety.
READ ALSO: Wellness And Proactive Health Leading The Way To A Healthier Future – Pharmacy 2.0
